Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for biote Corp. (BTMD : NSDQ)

• Company Description    BioTE Holdings, LLC is a medical practice-building business within the hormone optimization space. BioTE Holdings, LLC, formerly known as Haymaker Acquisition Corp. III, is based in NEW YORK. Number of Employees: 217

• Price / Volume Information    Yesterday's Closing Price: $2.71 Daily Weekly Monthly 20 Day Moving Average: 100,628 shares Shares Outstanding: 49.44 (millions) Market Capitalization: $133.98 (millions) Beta: 1.15 52 Week High: $6.98 52 Week Low: $2.65 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -2.17% -4.73% 12 Week -7.19% -11.04% Year To Date -56.15% -61.67%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1875 W. WALNUT HILL LN SUITE 100 - IRVING,TX 75038 USA ph: 844-604-1246 fax: 888-496-0394 ir@biote.com https://biote.com

• General Corporate Information    Officers Bret Christensen - Chief Executive Officer and Director Marc D. Beer - Executive Chairman and Director Robert C. Peterson - Chief Financial Officer Dana Jacoby - Director Mark Cone - Director Peer Information biote Corp. (BJCT) biote Corp. (CADMQ) biote Corp. (APNO) biote Corp. (UPDC) biote Corp. (IMTIQ) biote Corp. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 090683103 SIC: 2833 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/11/26 Share - Related Items Shares Outstanding: 49.44 Most Recent Split Date: (:1) Beta: 1.15 Market Capitalization: $133.98 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.02 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.42 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/11/26

• Fundamental Ratios P/E Current FY Estimate: 6.45 Trailing 12 Months: 5.42 PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: 3.54 Price / Sales: 0.68 EPS Growth vs. Year Ago Period: -33.33% vs. Previous Quarter: 120.00% Sales Growth vs. Year Ago Period: -6.67% vs. Previous Quarter: -1.86% ROE 09/30/25 - -20.43 06/30/25 - -21.00 03/31/25 - -19.44 ROA 09/30/25 - 15.49 06/30/25 - 18.26 03/31/25 - 20.12 Current Ratio 09/30/25 - - 06/30/25 - 0.98 03/31/25 - 1.42 Quick Ratio 09/30/25 - - 06/30/25 - 0.74 03/31/25 - 1.14 Operating Margin 09/30/25 - 9.25 06/30/25 - 10.36 03/31/25 - 11.10 Net Margin 09/30/25 - 14.72 06/30/25 - 15.73 03/31/25 - 10.93 Pre-Tax Margin 09/30/25 - - 06/30/25 - 19.17 03/31/25 - 10.93 Book Value 09/30/25 - - 06/30/25 - -2.14 03/31/25 - -1.55 Inventory Turnover 09/30/25 - - 06/30/25 - 3.94 03/31/25 - 3.60 Debt-to-Equity 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Capital 09/30/25 - - 06/30/25 - - 03/31/25 - -

Powered by Zacks Investment Research ©